Human papillomavirus (HPV) is the most common sexually transmitted disease, worldwide. Primary prevention thorough vaccination si able to reduce the burden of HPV-related lesions. Ten years ago the Food and drug Administration (FDA) approved the first vaccine against HPV. In the last decades, growing data on safety and effectiveness have been collected. In the present review we report the current knowledge on vaccine against HPV, highlighting the current value and prospective regarding the widespread diffusion of HPV vaccines. The role of emerging therapeutic vaccines is reviewed.

The role of human papillomavirus vaccines in cervical cancer: prevention and treatment / Bogani, G; Leone Roberti Maggiore, U; Signorelli, M; Martinelli, F; Ditto, A; Sabatucci, I; Mosca, L; Lorusso, D; Raspagliesi, F.. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - 122:(2018), pp. 92-97. [10.1016/j.critrevonc.2017.12.017]

The role of human papillomavirus vaccines in cervical cancer: prevention and treatment

Bogani G
;
2018

Abstract

Human papillomavirus (HPV) is the most common sexually transmitted disease, worldwide. Primary prevention thorough vaccination si able to reduce the burden of HPV-related lesions. Ten years ago the Food and drug Administration (FDA) approved the first vaccine against HPV. In the last decades, growing data on safety and effectiveness have been collected. In the present review we report the current knowledge on vaccine against HPV, highlighting the current value and prospective regarding the widespread diffusion of HPV vaccines. The role of emerging therapeutic vaccines is reviewed.
2018
cervical cancer; HPV; therapeutic vaccine; vaccine
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
The role of human papillomavirus vaccines in cervical cancer: prevention and treatment / Bogani, G; Leone Roberti Maggiore, U; Signorelli, M; Martinelli, F; Ditto, A; Sabatucci, I; Mosca, L; Lorusso, D; Raspagliesi, F.. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - 122:(2018), pp. 92-97. [10.1016/j.critrevonc.2017.12.017]
File allegati a questo prodotto
File Dimensione Formato  
Bogani_Papillomavirus-vaccines_2018.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 205.56 kB
Formato Adobe PDF
205.56 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1584215
Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 51
  • ???jsp.display-item.citation.isi??? 47
social impact